Chaoyang Xinrun Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chaoyang Xinrun Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TISOFWES. The owner is based in Chaoyang, Liaoning.

Rm 202-1, 2F, Bldg 1 Elec. Info. Eqpt.

Mfg. Industrial Park, Shuangta

Chaoyang, Liaoning 122000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TISOFWES
TISOFWES
Registered 2024

Trademark Classifications

Chaoyang Xinrun Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does Chaoyang Xinrun Technology Co., Ltd. have?

Chaoyang Xinrun Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chaoyang Xinrun Technology Co., Ltd. file in?

Chaoyang Xinrun Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 31 (Natural Agricultural Products). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.

What are Chaoyang Xinrun Technology Co., Ltd.'s most well-known trademarks?

Chaoyang Xinrun Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as TISOFWES. These are among 1 currently registered trademark in the portfolio.

What is Chaoyang Xinrun Technology Co., Ltd.'s trademark registration success rate?

Chaoyang Xinrun Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.